用口服直接作用抗病毒剂治疗的HCV诱导患者的B细胞克隆性
Basma Waly1, Mohammed Taha Abdel-Aal2, Shahira El-Etreby1
1Specialized Medical hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Asian Pacific journal of cancer prevention : APJCP
|June 28, 2023
概括
埃及的C型肝炎病毒 (HCV) 感染与B细胞异常有关. 直接作用抗病毒疗法 (DAA) 部分降低了这些标记物,这表明IgH重组可以预测淋巴增殖性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
背景情况:
- 肝炎C病毒 (HCV) 构成了全球卫生挑战,埃及的患病率高 (14.7%).
- 冠状病毒感染可以影响B淋巴细胞,可能导致单克隆B细胞扩张,这是免疫球蛋白重链 (IgH) 基因重组所表明的.
- 评估埃及HCV患者的IgH重组对于了解疾病机制和治疗反应至关重要.
研究的目的:
- 确定埃及慢性HCV患者IgH基因重组的患病率.
- 研究口服直接作用抗病毒疗法 (DAA) 对IgH克隆性标记物的回归的影响.
主要方法:
- 该研究包括78名被诊断患有慢性HCV感染的埃及患者.
- 根据BIOMED-2国际指导方针,采用聚合酶链反应 (PCR) 分析来检测IgH重组.
- 分析将IgH克隆性与病毒载量,肝酶和淋巴增殖性疾病 (LPD) 的存在相关联.
主要成果:
- 在克隆IgH患者中观察到HCV-RNA和阿氨酸转胺酶 (ALT) 水平的显著增加.
- 卡帕和兰巴自由光链水平仅在患有LPD的克隆IgH患者中显著增加.
- 在37.17%的患者中检测到IgH克隆性 (7.69%患有LPD,29.48%没有LPD).
- 在DAA治疗和HCV根除后,37%的检测到的IgH克隆性消失了.
结论:
- 有或没有利巴维林 (RBV) 的DAA疗法对于治疗埃及HCV患者是安全有效的.
- DAA疗法部分,但不是完全,消除IgH克隆性.
- IgH重新排列是预测慢性HCV患者的LPD风险的有价值指标.
相关概念视频
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
T Cell Activation and Clonal Selection
837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
837


